ASCVD Risk Reduction Recommendations: Who Benefits From High Intensity Statins? Which Non-Statin Therapies to Choose? What Is the Efficacy of Inclisiran in Patients With Elevated LDL Cholesterol? | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

Cardiometabolic Health Congress (CMHC)

ASCVD Risk Reduction Recommendations: Who Benefits From High Intensity Statins? Which Non-Statin Therapies to Choose? What Is the Efficacy of Inclisiran in Patients With Elevated LDL Cholesterol?

By Cardiometabolic Health Congress (CMHC) FEATURING Margo Minissian

By Cardiometabolic Health Congress (CMHC) FEATURING Margo Minissian

166 views

January 18, 2021

Comments 0

Login to view comments. Click here to Login